Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Kyverna Therapeutics (KYTX)

Kyverna Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KYTX
DateTimeSourceHeadlineSymbolCompany
29/05/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KYTXKyverna Therapeutics Inc
14/05/202421:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KYTXKyverna Therapeutics Inc
14/05/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KYTXKyverna Therapeutics Inc
14/05/202421:05PR Newswire (US)Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:KYTXKyverna Therapeutics Inc
11/04/202422:01PR Newswire (US)Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune DiseasesNASDAQ:KYTXKyverna Therapeutics Inc
29/03/202418:59PR Newswire (US)First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in MedNASDAQ:KYTXKyverna Therapeutics Inc
26/03/202420:05PR Newswire (US)Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:KYTXKyverna Therapeutics Inc
08/03/202400:26PR Newswire (US)Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple SclerosisNASDAQ:KYTXKyverna Therapeutics Inc
12/02/202421:39PR Newswire (US)Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:KYTXKyverna Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KYTX